Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haley Hedlin

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Pulmonary Circulation|March 4, 2025
Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical CenterCyrus A Kholdani, Justin H Lee, Kai E Swenson, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2017
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial HypertensionRoham T Zamanian, Haley Hedlin, Paul Greuenwald, et al.
Annals of the American Thoracic Society|March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryRoberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Lancet Regional Health. Americas|March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in BrazilMarco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
Med (New York, N.Y.)|April 18, 2022
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infectionAravind Natarajan, Soumaya Zlitni, Erin F Brooks, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Journal of Clinical and Translational Science|September 25, 2023
The evolving role of data & safety monitoring boards for real-world clinical trialsBryan J Bunning, Haley Hedlin, Jonathan H Chen, et al.
Journal of Biopharmaceutical Statistics|June 13, 2022
Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trialsAriadna Garcia, Vidhya Balasubramanian, Justin Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
Research Square|February 8, 2022
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Pulmonary Circulation|March 4, 2025
Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical CenterCyrus A Kholdani, Justin H Lee, Kai E Swenson, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2017
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial HypertensionRoham T Zamanian, Haley Hedlin, Paul Greuenwald, et al.
Annals of the American Thoracic Society|March 3, 2022
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association RegistryRoberto J Bernardo, Di Lu, Ramon L Ramirez, et al.
Lancet Regional Health. Americas|March 14, 2025
Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in BrazilMarco Antonio Moreira Puga, Roberto Dias de Oliveira, Patricia Vieira da Silva, et al.
Med (New York, N.Y.)|April 18, 2022
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infectionAravind Natarajan, Soumaya Zlitni, Erin F Brooks, et al.
BMJ Public Health|July 7, 2025
Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in BrazilJuliana Barros Verruck, Marco Antonio Moreira Puga, Roberto Dias de Oliveira, et al.
Journal of Clinical and Translational Science|September 25, 2023
The evolving role of data & safety monitoring boards for real-world clinical trialsBryan J Bunning, Haley Hedlin, Jonathan H Chen, et al.
Journal of Biopharmaceutical Statistics|June 13, 2022
Lessons learned in the Apple Heart Study and implications for the data management of future digital clinical trialsAriadna Garcia, Vidhya Balasubramanian, Justin Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2023
Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialJoseph E Levitt, Haley Hedlin, Sophie Duong, et al.
Research Square|February 8, 2022
Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, et al.
Pageof 8